FGD1 gene

FYVE, RhoGEF and PH domain containing 1

The FGD1 gene provides instructions for making a protein that functions as a guanine nucleotide exchange factor (GEF). GEFs turn on (activate) proteins called GTPases, which play an important role in chemical signaling within cells. GTPases are turned off (inactivated) when they are attached (bound) to a molecule called GDP and are turned on (activated) when they are bound to another molecule called GTP.

The FGD1 protein activates the GTPase known as Cdc42 by stimulating the exchange of GDP for GTP. Once Cdc42 is active, it transmits signals that are critical for various aspects of development before and after birth, particularly the development of bones. The FGD1 protein may also be involved in maintenance (remodeling) of the extracellular matrix, which is the intricate lattice of proteins and other molecules that forms in the spaces between cells. Through this process, the protein appears to play a role in cell movement (migration) and the remodeling of blood vessels.

More than 40 mutations in the FGD1 gene have been found to cause Aarskog-Scott syndrome, a rare condition that occurs primarily in males. Affected boys typically have distinctive facial features, genital abnormalities, childhood short stature, and other skeletal abnormalities. The FGD1 gene mutations lead to the production of an abnormally functioning FGD1 protein, which disrupts Cdc42 signaling. Altering the transmission of Cdc42 signals likely impairs normal development of bones and other tissues, resulting in the wide variety of abnormalities that occur in people with Aarskog-Scott syndrome.

Cytogenetic Location: Xp11.22, which is the short (p) arm of the X chromosome at position 11.22

Molecular Location: base pairs 54,445,454 to 54,496,234 on the X chromosome (Homo sapiens Updated Annotation Release 109.20200522, GRCh38.p13) (NCBI)

Cytogenetic Location: Xp11.22, which is the short (p) arm of the X chromosome at position 11.22
  • AAS
  • faciogenital dysplasia protein
  • FGDY
  • ZFYVE3